| Year |
Citation |
Score |
| 2000 |
Waldmeier PC, Boulton AA, Cools AR, Kato AC, Tatton WG. Neurorescuing effects of the GAPDH ligand CGP 3466B Journal of Neural Transmission, Supplement. 197-214. PMID 11205140 DOI: 10.1007/978-3-7091-6301-6_13 |
0.309 |
|
| 1999 |
Li XM, Juorio AV, Qi J, Boulton AA. L-deprenyl induces aromatic L-amino acid decarboxylase (AADC) mRNA in the rat substantia nigra and ventral tegmentum: An in situ hybridization study Molecular and Chemical Neuropathology. 35: 149-155. PMID 10343976 DOI: 10.1007/Bf02815121 |
0.315 |
|
| 1996 |
Zhang X, Zuo DM, Davis BA, Boulton AA, Yu PH. Immunohistochemical evidence of neuroprotection by R(-)-deprenyl and N-(2-hexyl)-N-methylpropargylamine on DSP-4-induced degeneration of rat brain noradrenergic axons and terminals. Journal of Neuroscience Research. 43: 482-9. PMID 8699534 DOI: 10.1002/(Sici)1097-4547(19960215)43:4<482::Aid-Jnr9>3.0.Co;2-B |
0.305 |
|
| 1995 |
Paterson IA, Davis BA, Durden DA, Juorio AV, Yu PH, Ivy G, Milgram W, Mendonca A, Wu P, Boulton AA. Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain Neurochemical Research. 20: 1503-1510. PMID 8789614 DOI: 10.1007/Bf00970600 |
0.332 |
|
| 1995 |
Yu PH, Davis BA, Zhang X, Zuo DM, Fang J, Lai CT, Li XM, Paterson IA, Boulton AA. Neurochemical, neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines; new MAO-B inhibitors without amphetamine-like properties Progress in Brain Research. 106: 113-121. PMID 8584647 DOI: 10.1016/S0079-6123(08)61208-X |
0.338 |
|
| 1995 |
Milgram NW, Ivy GO, Murphy MP, Head E, Wu PH, Ruehl WW, Yu PH, Durden DA, Davis BA, Boulton AA. Effects of chronic oral administration of L-deprenyl in the dog. Pharmacology, Biochemistry, and Behavior. 51: 421-8. PMID 7667363 DOI: 10.1016/0091-3057(94)00417-H |
0.336 |
|
| 1995 |
Yu PH, Davis BA, Boulton AA. Aliphatic propargylamines, a new series of potent selective, irreversible non-amphetamine-like MAO-B inhibitors: Their structures, function and pharmacological implications Advances in Experimental Medicine and Biology. 363: 17-23. PMID 7618520 DOI: 10.1007/978-1-4615-1857-0_3 |
0.339 |
|
| 1995 |
Fang J, Yu PH, Boulton AA, Gorrod JW. Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia Psychopharmacology. 118: 206-212. PMID 7617809 DOI: 10.1007/Bf02245841 |
0.312 |
|
| 1994 |
Yu PH, Davis BA, Durden DA, Barber A, Terleckyj I, Nicklas WG, Boulton AA. Neurochemical and neuroprotective effects of some aliphatic propargylamines: New selective nonamphetamine-like monoamine oxidase B inhibitors Journal of Neurochemistry. 62: 697-704. PMID 8294932 DOI: 10.1046/J.1471-4159.1994.62020697.X |
0.343 |
|
| 1994 |
Yu PH, Davis BA, Fang J, Boulton AA. Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus Journal of Neurochemistry. 63: 1820-1828. PMID 7931338 DOI: 10.1046/J.1471-4159.1994.63051820.X |
0.304 |
|
| 1994 |
Yu PH, Davis BA, Boulton AA, Zuo DM. Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; Pharmacological implications Journal of Neural Transmission, Supplement. 397-406. PMID 7931256 DOI: 10.1007/978-3-7091-9324-2_53 |
0.305 |
|
| 1994 |
Zhu M‐, Juorio AV, Paterson IA, Boulton AA. Regulation of aromatic l‐amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists British Journal of Pharmacology. 112: 23-30. PMID 7913379 DOI: 10.1111/J.1476-5381.1994.Tb13023.X |
0.322 |
|
| 1993 |
Dyck LE, Durden DA, Boulton AA. Effects of monoamine oxidase inhibitors on the acid metabolites of some trace amines and of dopamine in the rat striatum Biochemical Pharmacology. 45: 1317-1322. PMID 8466551 DOI: 10.1016/0006-2952(93)90285-5 |
0.359 |
|
| 1993 |
Li XM, Qi J, Juorio AV, Boulton AA. Reduction in glial fibrillary acidic protein mRNA abundance induced by (-)-deprenyl and other monoamine oxidase B inhibitors in C6 glioma cells Journal of Neurochemistry. 61: 1573-1576. PMID 8377010 DOI: 10.1111/J.1471-4159.1993.Tb13660.X |
0.304 |
|
| 1993 |
Li XM, Juorio AV, Boulton AA. NSD-1015 alters the gene expression of aromatic l-amino acid decarboxylase in rat PC12 pheochromocytoma cells Neurochemical Research. 18: 915-919. PMID 8371833 DOI: 10.1007/Bf00998277 |
0.329 |
|
| 1993 |
Dyck LE, Durden DA, Boulton AA. Conjugation of phenylacetic acid and m- and p-hydroxyphenylacetic acids in the rat striatum Life Sciences. 53: 901-909. PMID 8366757 DOI: 10.1016/0024-3205(93)90442-6 |
0.329 |
|
| 1993 |
Zhu MY, Juorio AV, Alick Paterson I, Boulton AA. Regulation of striatal aromatic L-amino acid decarboxylase: Effects of blockade or activation of dopamine receptors European Journal of Pharmacology. 238: 157-164. PMID 8104805 DOI: 10.1016/0014-2999(93)90843-7 |
0.324 |
|
| 1993 |
Davis BA, Kennedy SH, Durden DA, D'Souza J, Goldbloom DS, Boulton AA. The effect of the mao-a selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa Progress in Neuropsychopharmacology and Biological Psychiatry. 17: 747-763. PMID 7504824 DOI: 10.1016/0278-5846(93)90057-Y |
0.31 |
|
| 1992 |
Zhu MY, Juorio AV, Paterson IA, Boulton AA. Regulation of Aromatic l‐Amino Acid Decarboxylase by Dopamine Receptors in the Rat Brain Journal of Neurochemistry. 58: 636-641. PMID 1729407 DOI: 10.1111/J.1471-4159.1992.Tb09765.X |
0.34 |
|
| 1992 |
Dyck LE, Boulton AA. Reversible, amine-Selective effects of acute and chronic brofaromine treatment in the rat Life Sciences. 51: 59-66. PMID 1614274 DOI: 10.1016/0024-3205(92)90219-F |
0.32 |
|
| 1992 |
Yu PH, Davis BA, Boulton AA. Neuronal and astroglial monoamine oxidase: Pharmacological implications of specific MAO-B inhibitors Progress in Brain Research. 94: 309-315. PMID 1287721 DOI: 10.1016/S0079-6123(08)61760-4 |
0.311 |
|
| 1991 |
Boulton AA. Phenylethylaminergic modulation of catecholaminergic neurotransmission Progress in Neuropsychopharmacology and Biological Psychiatry. 15: 139-156. PMID 1651528 DOI: 10.1016/0278-5846(91)90076-D |
0.338 |
|
| 1990 |
Boulton AA, Juorio AV, Paterson IA. Phenylethylamine in the CNS: effects of monoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission Journal of Neural Transmission, Supplement. 29: 119-129. PMID 2193105 DOI: 10.1007/978-3-7091-9050-0_12 |
0.325 |
|
| 1990 |
Yu PH, Boulton AA. Effect of trimipramine, an atypical tricyclic antidepressant, on the activities of various enzymes involved in the metabolism of biogenic amines Progress in Neuropsychopharmacology and Biological Psychiatry. 14: 409-416. PMID 1972801 DOI: 10.1016/0278-5846(90)90028-F |
0.343 |
|
| 1989 |
Dyck LE, Boulton AA. Effects of antidepressant drugs on inositol phospholipid hydrolysis in rat cerebral cortical slices Neurochemical Research. 14: 1047-1052. PMID 2594139 DOI: 10.1007/Bf00965609 |
0.306 |
|
| 1989 |
Dyck LE, Boulton AA. Effects of β-phenylethylamine on polyphosphoinositide turnover in rat cerebral cortex Neurochemical Research. 14: 63-67. PMID 2540445 DOI: 10.1007/Bf00969759 |
0.301 |
|
| 1988 |
Dyck LE, Juorio AV, Durden DA, Boulton AA. Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase Naunyn-Schmiedeberg's Archives of Pharmacology. 337: 279-283. PMID 3393230 DOI: 10.1007/Bf00168839 |
0.349 |
|
| 1988 |
Dewar KM, Dyck LE, Durden DA, Boulton AA. Involvement of brain trace amines in the behavioural effects of phenelzine Neurochemical Research. 13: 113-119. PMID 3362290 DOI: 10.1007/Bf00973322 |
0.31 |
|
| 1988 |
Durden DA, Nguyen TV, Boulton AA. Kinetics of intraventricularly injected trace amines and their deuterated isotopomers Neurochemical Research. 13: 943-950. PMID 3216952 DOI: 10.1007/Bf00970766 |
0.331 |
|
| 1987 |
Davis BA, Dawson B, Boulton AA, Yu PH, Durden DA. Investigation of some biological trait markers in migraine: Deuterated tyramine challenge test, monoamine oxidase, phenolsulfotransferase and plasma and urinary biogenic amine and acid metabolite levels Headache. 27: 384-389. PMID 3477534 DOI: 10.1111/J.1526-4610.1987.Hed2707384.X |
0.314 |
|
| 1987 |
O'Regan D, Kwok RP, Yu PH, Bailey BA, Greenshaw AJ, Boulton AA. A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition. Psychopharmacology. 92: 42-7. PMID 3110827 DOI: 10.1007/Bf00215477 |
0.304 |
|
| 1987 |
Boulton AA, Davis BA. The metabolism of ingested deuterium‐labelled p‐tyramine in normal subjects Biomedical &Amp; Environmental Mass Spectrometry. 14: 207-211. PMID 2955823 DOI: 10.1002/Bms.1200140503 |
0.302 |
|
| 1987 |
Bailey BA, Philips SR, Boulton AA. In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine Neurochemical Research. 12: 173-178. PMID 2437473 DOI: 10.1007/Bf00979534 |
0.324 |
|
| 1986 |
Juorio AV, Greenshaw AJ, Boulton AA. Effects of acute and chronic phenelzine on regional monoamine metabolism in rats and its potentiation by deuterium substitution. Naunyn-Schmiedeberg's Archives of Pharmacology. 333: 240-5. PMID 2429193 DOI: 10.1007/Bf00512936 |
0.334 |
|
| 1985 |
Dyck LE, Durden DA, Boulton AA. Formation of β-phenylethylamine from the antidepressant, β-phenylethylhydrazine Biochemical Pharmacology. 34: 1925-1929. PMID 4004908 DOI: 10.1016/0006-2952(85)90310-7 |
0.305 |
|
| 1985 |
Dewar KM, Dyck LE, Durden DA, Boulton AA. Changes in brain catecholamine levels following DL-dopa are not potentiated by deuterium substitution Progress in Neuropsychopharmacology and Biological Psychiatry. 9: 675-680. PMID 3937178 DOI: 10.1016/0278-5846(85)90039-9 |
0.332 |
|
| 1984 |
Juorio AV, Boulton AA. The effect of zimelidine and amitriptyline on the brain concentration of some indolic and phenolic monoamines in the mouse European Journal of Pharmacology. 97: 191-196. PMID 6200338 DOI: 10.1016/0014-2999(84)90450-3 |
0.338 |
|
| 1983 |
Dyck LE, Durden DA, Yu PH, Davis BA, Boulton AA. Potentiation of the biochemical effects of β-phenylethylhydrazine by deuterium substitution Biochemical Pharmacology. 32: 1519-1522. PMID 6860370 DOI: 10.1016/0006-2952(83)90475-6 |
0.339 |
|
| 1983 |
Dyck LE, Yang CR, Boulton AA. The biosynthesis of p-tyramine, m-tyramine, and β-phenylethylamine by rat striatal slices Journal of Neuroscience Research. 10: 211-220. PMID 6632007 DOI: 10.1002/Jnr.490100209 |
0.3 |
|
| 1983 |
Dourish CT, Dewar KM, Dyck LE, Boulton AA. Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution Psychopharmacology. 81: 122-125. PMID 6415742 DOI: 10.1007/Bf00429005 |
0.313 |
|
| 1983 |
Jones RSG, Juorio AV, Boulton AA. Changes in levels of dopamine and tyramine in the rat caudate nucleus following alterations of impulse flow in the nigrostriatal pathway Journal of Neurochemistry. 40: 396-401. PMID 6130125 DOI: 10.1111/J.1471-4159.1983.Tb11295.X |
0.346 |
|
| 1982 |
Dourish CT, Boulton AA, Dyck LE. Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant Progress in Neuropsychopharmacology and Biological Psychiatry. 6: 383-388. PMID 6891805 DOI: 10.1016/S0278-5846(82)80112-7 |
0.318 |
|
| 1982 |
Dourish CT, Davis BA, Dyck LE, Jones RSG, Boulton AA. Alterations in trace amine and trace acid concentrations in isolated aggressive mice Pharmacology, Biochemistry and Behavior. 17: 1291-1294. PMID 6891793 DOI: 10.1016/0091-3057(82)90137-X |
0.305 |
|
| 1979 |
Petrali EH, Boulton AA, Dyck LE. Uptake of para-tyramine and meta-tyramine into slices of the caudate nucleus and hypothalamus of the rat Neurochemical Research. 4: 633-642. PMID 492450 DOI: 10.1007/Bf00964440 |
0.321 |
|
| 1977 |
Hui KS, Davis BA, Boulton AA. Analysis of copper in brain by the mass-spectrometric integrated-ioncurrent procedure. Neurochemical Research. 2: 495-506. PMID 24272241 DOI: 10.1007/Bf00966010 |
0.303 |
|
| 1977 |
BOULTON AA, JUORIO AV, PHILIPS SR, WU PH. THE EFFECTS OF RESERPINE AND 6‐HYDROXYDOPAMINE ON THE CONCENTRATIONS OF SOME ARYLALKYLAMINES IN RAT BRAIN British Journal of Pharmacology. 59: 209-214. PMID 837000 DOI: 10.1111/J.1476-5381.1977.Tb06996.X |
0.34 |
|
| 1976 |
Yu PH, Boulton AA, Wu PH. Some observations on the interaction of dopamine β hydroxylase and its natural inhibitors in the rat brain Canadian Journal of Biochemistry. 54: 988-991. PMID 1000363 DOI: 10.1139/O76-142 |
0.332 |
|
| 1976 |
Danielson TJ, Boulton AA. Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate European Journal of Pharmacology. 37: 257-264. PMID 954809 DOI: 10.1016/0014-2999(76)90033-9 |
0.317 |
|
| 1974 |
Boulton AA, Dyck LE, Durden DA. Hydroxylation of β-phenylethylamine in the rat Life Sciences. 15: 1673-1683. PMID 4550004 DOI: 10.1016/0024-3205(74)90334-8 |
0.314 |
|
| 1974 |
Boulton AA, Dyck LE. Biosynthesis and excretion of meta and para tyramine in the rat Life Sciences. 14: 2497-2506. PMID 4549972 DOI: 10.1016/0024-3205(74)90146-5 |
0.345 |
|
| 1973 |
Wu PH, Boulton AA. Distribution and metabolism of tryptamine in rat brain Canadian Journal of Biochemistry. 51: 1104-1112. PMID 4725358 DOI: 10.1139/O73-144 |
0.325 |
|
| 1973 |
Boulton AA, Wu PH. Biosynthesis of cerebral phenolic amines. II. In vivo regional formation of p-tyramine and octopamine from tyrosine and dopamine. Biochemistry and Cell Biology. 51: 428-435. PMID 4572198 DOI: 10.1139/O73-050 |
0.307 |
|
| 1972 |
Boulton AA, Wu PH. Biosynthesis of cerebral phenolic amines. I. In vivo formation of p-tyramine, octopamine, and synephrine. Biochemistry and Cell Biology. 50: 261-267. PMID 4553609 DOI: 10.1139/O72-037 |
0.318 |
|
| Show low-probability matches. |